The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor-infiltrating lymphocytes (TILs) and PDL1 expression in ovarian cancer (OC): Evolution with neoadjuvant chemotherapy (NCT) and prognostic value.
 
Soizick Mesnage
No Relationships to Disclose
 
Catherine Genestie
No Relationships to Disclose
 
Aurelie Auguste
No Relationships to Disclose
 
Erwann Pain
No Relationships to Disclose
 
Sebastien Gouy
Consulting or Advisory Role - Roche
 
Philippe Morice
No Relationships to Disclose
 
Enrica Bentivegna
No Relationships to Disclose
 
Catherine Lhomme
Honoraria - Amgen; PharmaMar; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Janssen; Roche
 
Patricia Pautier
Consulting or Advisory Role - GlaxoSmithKline; PharmaMar; Roche
Travel, Accommodations, Expenses - PharmaMar
 
Ariane Dunan
No Relationships to Disclose
 
Audrey Le Formal
No Relationships to Disclose
 
Julien Adam
No Relationships to Disclose
 
Alexandra Leary
Honoraria - Pharmamar
Consulting or Advisory Role - Clovis Oncology; GamaMabs Pharma; pfizer
Speakers' Bureau - Pharmamar
Research Funding - Clovis Oncology (Inst); Genentech (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - PharmaMar; Roche